These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 35164621)

  • 1. Insight of the various
    Sarathi P; Padhi S
    Drug Dev Ind Pharm; 2021 Oct; 47(10):1523-1534. PubMed ID: 35164621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Comprehensive Insight on Pharmaceutical Co-crystals for Improvement of Aqueous Solubility.
    Malik J; Khatkar A; Nanda A
    Curr Drug Targets; 2023; 24(2):157-170. PubMed ID: 36380409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solubility prediction, solvate and cocrystal screening as tools for rational crystal engineering.
    Loschen C; Klamt A
    J Pharm Pharmacol; 2015 Jun; 67(6):803-11. PubMed ID: 25851032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent Advancements in Pharmaceutical Cocrystals, Preparation Methods, and their Applications.
    Manchanda D; Kumar A; Nanda A
    Curr Pharm Des; 2021; 27(44):4477-4495. PubMed ID: 33858309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of a glutaric acid cocrystal to improve oral bioavailability of a low solubility API.
    McNamara DP; Childs SL; Giordano J; Iarriccio A; Cassidy J; Shet MS; Mannion R; O'Donnell E; Park A
    Pharm Res; 2006 Aug; 23(8):1888-97. PubMed ID: 16832611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient cocrystal coformer screening based on a Machine learning Strategy: A case study for the preparation of imatinib cocrystal with enhanced physicochemical properties.
    Liang X; Liu S; Li Z; Deng Y; Jiang Y; Yang H
    Eur J Pharm Biopharm; 2024 Mar; 196():114201. PubMed ID: 38309538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coamorphous Active Pharmaceutical Ingredient-Small Molecule Mixtures: Considerations in the Choice of Coformers for Enhancing Dissolution and Oral Bioavailability.
    Newman A; Reutzel-Edens SM; Zografi G
    J Pharm Sci; 2018 Jan; 107(1):5-17. PubMed ID: 28989014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmaceutical Cocrystal: An Antique and Multifaceted Approach.
    Panzade PS; Shendarkar GR
    Curr Drug Deliv; 2017; 14(8):1097-1105. PubMed ID: 27758692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-Crystallization: A Novel Technique to Improvise the Pharmaceutical Characteristics of API's.
    Kumar A; Kumar M
    Curr Drug Targets; 2023; 24(11):870-888. PubMed ID: 37496134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cocrystal solubility product analysis - Dual concentration-pH mass action model not dependent on explicit solubility equations.
    Avdeef A
    Eur J Pharm Sci; 2017 Dec; 110():2-18. PubMed ID: 28392495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydrochloride salt co-crystals: preparation, characterization and physicochemical studies.
    Parmar VK; Shah SA
    Pharm Dev Technol; 2013; 18(2):443-53. PubMed ID: 22686294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rational coformer or solvent selection for pharmaceutical cocrystallization or desolvation.
    Abramov YA; Loschen C; Klamt A
    J Pharm Sci; 2012 Oct; 101(10):3687-97. PubMed ID: 22821740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of Poor Solubility of a Salt-Cocrystal Hydrate: A Case Study of the Common-Ion Effect in Betrixaban, an Anticoagulant Drug.
    Devarapalli R; Indukuri A; Bollineni M; Mondal A; Reddy CM; Chennuru R
    Mol Pharm; 2021 Mar; 18(3):1138-1149. PubMed ID: 33528261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-crystal formation based on structural matching.
    Zhou L; Dodd S; Capacci-Daniel C; Garad S; Panicucci R; Sethuraman V
    Eur J Pharm Sci; 2016 Jun; 88():191-201. PubMed ID: 26948852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amino Acids as the Potential Co-Former for Co-Crystal Development: A Review.
    Nugrahani I; Jessica MA
    Molecules; 2021 May; 26(11):. PubMed ID: 34071731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmaceutical Cocrystal: A Novel Approach to Tailor the Biopharmaceutical Properties of a Poorly Water Soluble Drug.
    Srivastava D; Fatima Z; Kaur CD; Tulsankar SL; Nashik SS; Rizvi DA
    Recent Pat Drug Deliv Formul; 2019; 13(1):62-69. PubMed ID: 30848223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal Engineering of Pharmaceutical Cocrystals in the Discovery and Development of Improved Drugs.
    Bolla G; Sarma B; Nangia AK
    Chem Rev; 2022 Jul; 122(13):11514-11603. PubMed ID: 35642550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Coformer Selection on In Vitro and In Vivo Performance of Adefovir Dipivoxil Cocrystals.
    Li L; Pang Z; Ma K; Gao Y; Zheng D; Wei Y; Zhang J; Qian S
    Pharm Res; 2021 Oct; 38(10):1777-1791. PubMed ID: 34729701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioinspired co-crystals of Imatinib providing enhanced kinetic solubility.
    Reggane M; Wiest J; Saedtler M; Harlacher C; Gutmann M; Zottnick SH; Piechon P; Dix I; Müller-Buschbaum K; Holzgrabe U; Meinel L; Galli B
    Eur J Pharm Biopharm; 2018 Jul; 128():290-299. PubMed ID: 29733951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mechanism of binding with the α-glucosidase in vitro and the evaluation on hypoglycemic effect in vivo: Cocrystals involving synergism of gallic acid and conformer.
    Xue N; He B; Jia Y; Yang C; Wang J; Li M
    Eur J Pharm Biopharm; 2020 Nov; 156():64-74. PubMed ID: 32890659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.